Your session is about to expire
← Back to Search
PreVenture Training + Implementation Facilitation (PTtT+IF) for Substance Use Disorder (CUSP Trial)
N/A
Waitlist Available
Led By Patricia Conrod, PhD
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-intervention), 12 months, 24 months
Awards & highlights
CUSP Trial Summary
This trial aims to evaluate the long-term effects of a personality-targeted school-based prevention program on delaying the onset of drug and alcohol use in adolescence over three years across Canada.
Eligible Conditions
- Substance Use Disorder
- Adolescent Behaviors
- Adolescent Development
CUSP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pre-intervention), 12 months, 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-intervention), 12 months, 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness (): Severity of substance use problems
Implementation Facilitation (): Severity of substance use problems
Secondary outcome measures
Effectiveness (): Frequency of cannabis use
Effectiveness (): Frequency of illicit substance use
Effectiveness (): Frequency of non-medical prescription drug use
+2 moreCUSP Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: PreVenture Training + Implementation Facilitation (PTtT+IF)Experimental Treatment1 Intervention
Schools randomized this arm will receive the standard PreVenture TtT protocol plus an additional Implementation Facilitation package that will contain 3 new components designed to increase the likelihood that schools will continue to implement the program with high quality and satisfaction: 1) Youth Engagement, 2) ongoing coaching and supervision for Facilitators, and 3) access to easy-to-use performance metrics.
Group II: PreVenture Training (PTtT)Experimental Treatment1 Intervention
Schools randomized to this arm will identify 4 staff members to participate in a 2-day training workshop + 3 hours of supervised practice and will be provided with access to screening and PreVenture intervention materials through the local trainer. Local trainers will deliver 2-day workshops and then supervise school staff in the delivery of two 90-minute group sessions (for at least one personality profile).
Group III: Control (TAU)Active Control1 Intervention
For schools randomized to this arm, students will have usual access to drug and alcohol prevention through the standard curriculum and mental health care provided through student counseling at the participating schools. The schools will be incentivized to participate in the study with the promise of free PreVenture training and materials in subsequent years of the trial. Information on other drug prevention efforts implemented at the school will be collected, but the randomized design should control for any potential differences between intervention conditions on this random factor.
Find a Location
Who is running the clinical trial?
St. Justine's HospitalLead Sponsor
196 Previous Clinical Trials
66,529 Total Patients Enrolled
University of British ColumbiaOTHER
1,418 Previous Clinical Trials
2,454,618 Total Patients Enrolled
Center for Addiction and Mental HealthUNKNOWN
1 Previous Clinical Trials
15 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger